69.33 USD
-0.37 (-0.53%)
Overall DXCM gets a fundamental rating of 7 out of 10. We evaluated DXCM against 185 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making DXCM a very profitable company, without any liquidiy or solvency issues. DXCM is growing strongly while it is still valued neutral. This is a good combination! This makes DXCM very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
- DXCM had positive earnings in the past year.
- DXCM had a positive operating cash flow in the past year.
- Each year in the past 5 years DXCM has been profitable.
- Each year in the past 5 years DXCM had a positive operating cash flow.
1.2 Ratios
- DXCM has a Return On Assets of 9.61%. This is amongst the best in the industry. DXCM outperforms 92.97% of its industry peers.
- DXCM has a Return On Equity of 26.44%. This is amongst the best in the industry. DXCM outperforms 97.30% of its industry peers.
- DXCM has a Return On Invested Capital of 15.72%. This is amongst the best in the industry. DXCM outperforms 95.68% of its industry peers.
- DXCM had an Average Return On Invested Capital over the past 3 years of 11.25%. This is above the industry average of 8.84%.
- The 3 year average ROIC (11.25%) for DXCM is below the current ROIC(15.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROIC | 15.72% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
- With an excellent Profit Margin value of 15.96%, DXCM belongs to the best of the industry, outperforming 92.43% of the companies in the same industry.
- DXCM's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 18.41%, DXCM belongs to the top of the industry, outperforming 90.27% of the companies in the same industry.
- In the last couple of years the Operating Margin of DXCM has grown nicely.
- Looking at the Gross Margin, with a value of 60.20%, DXCM is in the better half of the industry, outperforming 61.08% of the companies in the same industry.
- DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DXCM is creating some value.
- Compared to 1 year ago, DXCM has more shares outstanding
- The number of shares outstanding for DXCM has been increased compared to 5 years ago.
- Compared to 1 year ago, DXCM has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 5.09 indicates that DXCM is not in any danger for bankruptcy at the moment.
- DXCM has a better Altman-Z score (5.09) than 76.76% of its industry peers.
- The Debt to FCF ratio of DXCM is 2.36, which is a good value as it means it would take DXCM, 2.36 years of fcf income to pay off all of its debts.
- DXCM has a Debt to FCF ratio of 2.36. This is amongst the best in the industry. DXCM outperforms 85.95% of its industry peers.
- A Debt/Equity ratio of 0.47 indicates that DXCM is not too dependend on debt financing.
- DXCM has a Debt to Equity ratio (0.47) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 5.09 |
ROIC/WACC1.65
WACC9.51%
2.3 Liquidity
- DXCM has a Current Ratio of 1.56. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of DXCM (1.56) is worse than 71.89% of its industry peers.
- DXCM has a Quick Ratio of 1.38. This is a normal value and indicates that DXCM is financially healthy and should not expect problems in meeting its short term obligations.
- DXCM has a worse Quick ratio (1.38) than 60.54% of its industry peers.
- The current and quick ratio evaluation for DXCM is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
- DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.41%, which is quite good.
- The Earnings Per Share has been growing by 29.25% on average over the past years. This is a very strong growth
- DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.21%.
- DXCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
3.2 Future
- The Earnings Per Share is expected to grow by 22.05% on average over the next years. This is a very strong growth
- DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.28% yearly.
EPS Next Y27.29%
EPS Next 2Y23.62%
EPS Next 3Y22.54%
EPS Next 5Y22.05%
Revenue Next Year15.35%
Revenue Next 2Y14.05%
Revenue Next 3Y13.65%
Revenue Next 5Y13.28%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 37.27 indicates a quite expensive valuation of DXCM.
- DXCM's Price/Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 71.89% of the companies in the same industry.
- DXCM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.33.
- With a Price/Forward Earnings ratio of 27.50, DXCM can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of DXCM indicates a somewhat cheap valuation: DXCM is cheaper than 74.05% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.12. DXCM is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.27 | ||
| Fwd PE | 27.5 |
4.2 Price Multiples
- 74.05% of the companies in the same industry are more expensive than DXCM, based on the Enterprise Value to EBITDA ratio.
- 83.78% of the companies in the same industry are more expensive than DXCM, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.46 | ||
| EV/EBITDA | 23.13 |
4.3 Compensation for Growth
- DXCM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
- DXCM's earnings are expected to grow with 22.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)1.27
EPS Next 2Y23.62%
EPS Next 3Y22.54%
5. Dividend
5.1 Amount
- DXCM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:DXCM (1/15/2026, 12:20:06 PM)
69.33
-0.37 (-0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-05 2026-02-05/amc
Inst Owners99.77%
Inst Owner Change0.23%
Ins Owners0.19%
Ins Owner Change0.55%
Market Cap27.04B
Revenue(TTM)4.52B
Net Income(TTM)720.70M
Analysts85.95
Price Target88.54 (27.71%)
Short Float %3.38%
Short Ratio2.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.05%
Min EPS beat(2)5.32%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)4.61%
EPS beat(12)10
Avg EPS beat(12)13.69%
EPS beat(16)11
Avg EPS beat(16)6.53%
Revenue beat(2)2
Avg Revenue beat(2)0.74%
Min Revenue beat(2)0.61%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.38%
Revenue beat(16)6
Avg Revenue beat(16)-0.58%
PT rev (1m)0.54%
PT rev (3m)-15.27%
EPS NQ rev (1m)-0.2%
EPS NQ rev (3m)-4.89%
EPS NY rev (1m)0.02%
EPS NY rev (3m)0.35%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-1.17%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.27 | ||
| Fwd PE | 27.5 | ||
| P/S | 5.99 | ||
| P/FCF | 25.46 | ||
| P/OCF | 18.67 | ||
| P/B | 9.92 | ||
| P/tB | 10.31 | ||
| EV/EBITDA | 23.13 |
EPS(TTM)1.86
EY2.68%
EPS(NY)2.52
Fwd EY3.64%
FCF(TTM)2.72
FCFY3.93%
OCF(TTM)3.71
OCFY5.36%
SpS11.58
BVpS6.99
TBVpS6.73
PEG (NY)1.37
PEG (5Y)1.27
Graham Number17.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| ROCE | 19.96% | ||
| ROIC | 15.72% | ||
| ROICexc | 77.75% | ||
| ROICexgc | 88.6% | ||
| OM | 18.41% | ||
| PM (TTM) | 15.96% | ||
| GM | 60.2% | ||
| FCFM | 23.51% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexgc growth 3Y55.18%
ROICexgc growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.47 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 158.02% | ||
| Cap/Sales | 8.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 134.63% | ||
| Profit Quality | 147.34% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 5.09 |
F-Score5
WACC9.51%
ROIC/WACC1.65
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
EPS Next Y27.29%
EPS Next 2Y23.62%
EPS Next 3Y22.54%
EPS Next 5Y22.05%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%
Revenue Next Year15.35%
Revenue Next 2Y14.05%
Revenue Next 3Y13.65%
Revenue Next 5Y13.28%
EBIT growth 1Y28.95%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year73.63%
EBIT Next 3Y36.34%
EBIT Next 5Y30.77%
FCF growth 1Y112.47%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y93.75%
OCF growth 3Y30.77%
OCF growth 5Y25.76%
DEXCOM INC / DXCM FAQ
Can you provide the ChartMill fundamental rating for DEXCOM INC?
ChartMill assigns a fundamental rating of 7 / 10 to DXCM.
Can you provide the valuation status for DEXCOM INC?
ChartMill assigns a valuation rating of 5 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.
Can you provide the profitability details for DEXCOM INC?
DEXCOM INC (DXCM) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for DXCM stock?
The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 37.27 and the Price/Book (PB) ratio is 9.92.